-
Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026
- August 31, 2023
- Posted by: admin
- Category: News
No CommentsIn August 2022, President Biden signed the Inflation Reduction Act of 2022 (P.L. 117-169) into law. For the first time, the law provides Medicare the ability to directly negotiate the prices of certain high expenditure, single source drugs without generic or biosimilar competition. Below is the list of 10 drugs covered under Medicare Part D
-
Bimervax, the COVID-19 vaccine developed by HIPRA Human Health, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
- August 26, 2023
- Posted by: admin
- Category: News
Bimervax, the COVID-19 vaccine developed by HIPRA Human Health, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
-
The The U.S. Food and Drug Administration has approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS).
- August 26, 2023
- Posted by: admin
- Category: News
The The U.S. Food and Drug Administration has approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS).
-
The U.S. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.
- August 26, 2023
- Posted by: admin
- Category: News
The U.S. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.
-
The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product listings, including ingredients, to the FDA.
- August 26, 2023
- Posted by: admin
- Category: News
The U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product listings, including ingredients, to the FDA.
-
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
- August 26, 2023
- Posted by: admin
- Category: News
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
-
To fight China monopoly, Indian Govt to approve for 4 mega bulk drugs parks
- November 15, 2019
- Posted by: admin
- Category: News
To fight China monopoly, Indian Govt to approve for 4 mega bulk drugs parks New Delhi: The Indian Government has decided to hasten the approvals for mega bulk drugs parks in the country to counter the China’s dominance in the sector. Bulk drugs, also known as active pharmaceutical ingredients (API), are the raw materials for the
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.